The crystal structure of human CD1d with and without α-galactosylceramide

[1]  B. Beutler,et al.  Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.

[2]  D. Ho,et al.  Recognition of bacterial glycosphingolipids by natural killer T cells , 2005, Nature.

[3]  G. Besra,et al.  Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Ho,et al.  Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Dwek,et al.  Molecular mechanism of lipopeptide presentation by CD1a. , 2005, Immunity.

[6]  A. Harris,et al.  Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. , 2004, The Journal of clinical investigation.

[7]  R. Proia,et al.  Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.

[8]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[9]  Jelena S. Bezbradica,et al.  Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct α- and β-Anomeric Glycolipids1 , 2004, The Journal of Immunology.

[10]  G. Besra,et al.  The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Steinman,et al.  The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation , 2004, The Journal of experimental medicine.

[12]  T. Yamamura,et al.  The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. , 2004, The Journal of clinical investigation.

[13]  M. Kronenberg,et al.  The Third Way: Progress on pathways of antigen processing and presentation by CD1 , 2004, Immunology and cell biology.

[14]  G. De Libero,et al.  Diacylated Sulfoglycolipids Are Novel Mycobacterial Antigens Stimulating CD1-restricted T Cells during Infection with Mycobacterium tuberculosis , 2004, The Journal of experimental medicine.

[15]  P. Savage,et al.  Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins , 2004, Science.

[16]  H. Young,et al.  Dissociation of NKT Stimulation, Cytokine Induction, and NK Activation In Vivo by the Use of Distinct TCR-Binding Ceramides1 , 2004, The Journal of Immunology.

[17]  P. Cresswell,et al.  Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells , 2004, Nature Immunology.

[18]  M. Tsuji,et al.  Superior Protection against Malaria and Melanoma Metastases by a C-glycoside Analogue of the Natural Killer T Cell Ligand α-Galactosylceramide , 2003, The Journal of experimental medicine.

[19]  Jelena S. Bezbradica,et al.  Another View of T Cell Antigen Recognition: Cooperative Engagement of Glycolipid Antigens by Va14Ja18 Natural TCR 1 , 2003, The Journal of Immunology.

[20]  N. Segal,et al.  Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells , 2003, The Journal of experimental medicine.

[21]  I. Wilson,et al.  Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å , 2003, Nature Immunology.

[22]  David I. Stuart,et al.  A procedure for setting up high-throughput nanolitre crystallization experiments. I. Protocol design and validation , 2003 .

[23]  David I. Stuart,et al.  A procedure for setting up high-throughput nanolitre crystallization experiments. II. Crystallization results , 2003 .

[24]  M. Kronenberg,et al.  The unconventional lifestyle of NKT cells , 2002, Nature Reviews Immunology.

[25]  K. Garcia,et al.  The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex1 , 2002, The Journal of Immunology.

[26]  Gerd Ritter,et al.  Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains , 2002, Nature Immunology.

[27]  John Sidney,et al.  Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au. , 2002, Immunity.

[28]  G. De Libero,et al.  Presentation of the Same Glycolipid by Different CD1 Molecules , 2002, The Journal of experimental medicine.

[29]  R. Locksley,et al.  Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S. , 2001, Immunity.

[30]  T. Yamamura,et al.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells , 2001, Nature.

[31]  A. Fersht,et al.  Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Fersht,et al.  Human CD1d–glycolipid tetramers generated by in vitro oxidative refolding chromatography , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Schmidt,et al.  Total synthesis of α-galactosyl cerebroside , 2000 .

[34]  M. Kronenberg,et al.  Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers , 2000, The Journal of experimental medicine.

[35]  I. Wilson,et al.  Structural requirements for antigen presentation by mouse CD1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Teyton,et al.  In Vivo Identification of Glycolipid Antigen–Specific T Cells Using Fluorescent Cd1d Tetramers , 2000, The Journal of experimental medicine.

[37]  M. Kronenberg,et al.  CD1-mediated antigen presentation of glycosphingolipids. , 2000, Microbes and infection.

[38]  G. Besra,et al.  CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection , 2000, Nature.

[39]  S. Porcelli,et al.  Murine CD1d-restricted T cell recognition of cellular lipids. , 2000, Immunity.

[40]  M. Kronenberg,et al.  Binding and Antigen Presentation of Ceramide-Containing Glycolipids by Soluble Mouse and Human Cd1d Molecules , 1999, The Journal of experimental medicine.

[41]  L. Kappos,et al.  Self glycolipids as T‐cell autoantigens , 1999, European journal of immunology.

[42]  M. Kronenberg,et al.  Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells. , 1998, Journal of immunology.

[43]  S. Porcelli,et al.  CD1d-restricted Recognition of Synthetic Glycolipid Antigens by Human Natural Killer T Cells , 1998, The Journal of experimental medicine.

[44]  M. Kronenberg,et al.  CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution , 1998, The Journal of experimental medicine.

[45]  V. Cerundolo,et al.  Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding. , 1998, Biochemistry.

[46]  Hiroshi Sato,et al.  CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. , 1997, Science.

[47]  B. Reinhold,et al.  Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. , 1997, Science.

[48]  P. A. Peterson,et al.  Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. , 1997, Science.

[49]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[50]  P. Andrew Karplus,et al.  Improved R-factors for diffraction data analysis in macromolecular crystallography , 1997, Nature Structural Biology.

[51]  P. Brennan,et al.  CD1-restricted T cell recognition of microbial lipoglycan antigens. , 1995, Science.

[52]  S. Porcelli,et al.  Recognition of a lipid antigen by GDI-restricted αβ+ T cells , 1994, Nature.

[53]  C. Milstein,et al.  Two classes of CD1 genes , 1989, European journal of immunology.

[54]  A. Fersht,et al.  The Crystal Structure of Human CD1b with a Bound Bacterial Glycolipid , 2004 .

[55]  D. Moody,et al.  Intracellular pathways of CD1 antigen presentation , 2003, Nature Reviews Immunology.

[56]  P. Savage,et al.  Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail–truncated CD1d , 2002, Nature Immunology.

[57]  K. Garcia,et al.  The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. , 2002, Journal of immunology.

[58]  S. Porcelli,et al.  The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. , 1999, Annual review of immunology.

[59]  S. Park,et al.  Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.